Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2024-2030
The Clinical Trial Equipment & Ancillary Solutions Market size was estimated at USD 4.21 billion in 2023 and expected to reach USD 4.58 billion in 2024, at a CAGR 8.81% to reach USD 7.62 billion by 2030.
Clinical trial equipment & ancillary solutions are specialized medical equipment and services used during clinical trials to accurately and effectively evaluate treatments, drugs, and devices. This equipment includes patient monitors, imaging systems, laboratory instruments, and automated data collection systems. It also includes ancillary services such as clinical trial management and regulatory support. Clinical trial equipment & ancillary solutions are essential components of any successful clinical trial as they provide the necessary tools and resources to ensure participants' safety and the trial results' accuracy. An ancillary solution for clinical trial equipment includes any tools, services, or products used to assist in completing a clinical trial. Rising investment in R&D activities for clinical trial equipment and ancillary solutions drives market growth by fueling innovation, improving data quality, expanding product offerings, ensuring regulatory compliance, addressing evolving trial needs, and attracting new market participants. Outsourcing clinical trial activities provides cost-effectiveness, access to expertise, expanded reach, streamlined operations, regulatory compliance, and scalability, further increasing the use of clinical trial equipment & ancillary solutions. Data security risks associated with cloud-based clinical trial solutions, such as unauthorized access and data breaches, create concerns about confidentiality, regulatory compliance, data integrity, and cybersecurity, hampering the clinical trial equipment & ancillary solutions market growth. Moreover, rising regulatory approvals for clinical trial equipment and government support, which increased trial activity, adoption of advanced technologies, innovation, and streamlined regulatory processes, have created market opportunities in the forecasted period.
Regional Insights
The clinical trials equipment & ancillary solutions market in the Americas is highly developing due to supportive governmental investments and initiatives for drug discovery and development and significant growth of clinical trial activities in the region. The Asia-Pacific region is an evolving market for clinical trial equipment & ancillary solutions owing to factors such as a large and diverse patient base and low costs that provide significant advantages for conducting clinical trials. Moreover, the stringent government norms in the EMEA region for ensuring the safety and efficacy of clinical trial equipment & ancillary solutions are making the market more competitive and standardized. The various government frameworks, including the European Medicines Agency (EMA), Clinical Trial Regulation 536/2014 (EU-CTR), and regional frameworks, monitor and regulate the use of clinical trial equipment & ancillary solutions in the region.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Clinical Trial Equipment & Ancillary Solutions Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Need to determine the safe and effective use of new drugs and medical device
- Outsourcing of clinical trial activity across the globe
- Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
- Market Restraints
- Data security risks associated with cloud-based clinical trial solutions
- Market Opportunities
- Government initiatives and support for drug development and clinical trials
- Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
- Market Challenges
- Complexities in procedures of cross border logistics for clinical trials
- Market Segmentation Analysis
- Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
- Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
- Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
- Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
- End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Equipment & Ancillary Solutions Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Equipment & Ancillary Solutions Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- RQM+ Acquires Libra Medical
RQM acquired Libra Medical to expand its reach into more markets while providing its customers with access to Libra Medical's reliable and innovative product portfolio. With this acquisition, RQM continues its mission to provide high-quality and cost-effective clinical trial equipment and ancillary solutions to clients worldwide.
Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
Lambda Therapeutics partnered with Medidata to automate and streamline its data management processes for greater clinical trial efficiency. Through advanced technology, Lambda Therapeutics manages its clinical trials more effectively and efficiently, allowing them to gather valuable insights from its data that can be used to make better decisions and enhance patient care outcomes.
Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
MedNet launched its DICOM Imaging capabilities within the iMedNet eClinical platform. This addition allows trial sponsors and contract research organizations to manage clinical trials efficiently and securely by providing an integrated electronic data capture and imaging management solution. This expansion of MedNet's offerings provides researchers with a comprehensive suite of tools for collecting, managing, and analyzing data from clinical studies, ultimately improving the quality of care for patients. With this capability, MedNet enables clinical trial sponsors to move faster with greater visibility into image collections.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Equipment & Ancillary Solutions Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systèmes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.
Market Segmentation & Coverage
This research report categorizes the Clinical Trial Equipment & Ancillary Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Equipment
- Imaging & Diagnostic Equipment
- Laboratory Equipment
- Services
- Ancillary Sourcing Services
- Equipment Leasing & Rental Services
- Procurement
- Supply & Logistics
- Data Management & Analysis Services
- Maintenance & Calibration Services
- Regulatory & Compliance Services
- Site Monitoring & Support Services
- Training & Consulting Services
- Systems
- Clinical Trial Management Systems
- Electronic Data Capture Systems
- Randomization & Trial Supply Management
- Type
- Biologic Drugs
- Medical Devices
- Small Molecules
- Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- End-Use
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations
- Medical Device Companies
- Indication
- Blood Disorders
- Cardiovascular Diseases
- CNS & Mental Disorders
- Digestive Disorders
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Oncology
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Ancillary Sourcing Services
- Equipment
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Need to determine the safe and effective use of new drugs and medical device
- 5.1.1.2. Outsourcing of clinical trial activity across the globe
- 5.1.1.3. Increasing investment in R&D activities for clinical trials equipment & ancillary solutions
- 5.1.2. Restraints
- 5.1.2.1. Data security risks associated with cloud-based clinical trial solutions
- 5.1.3. Opportunities
- 5.1.3.1. Government initiatives and support for drug development and clinical trials
- 5.1.3.2. Integration of artificial intelligence (AI) and data analytics in clinical trial solutions
- 5.1.4. Challenges
- 5.1.4.1. Complexities in procedures of cross border logistics for clinical trials
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing utilization of ancillary sourcing services for equipment leasing & rental services
- 5.2.2. Type: Increasing application of clinical trial equipment in the manufacturing process of biological drugs
- 5.2.3. Indication: Rising preferences for clinical trial equipment to analyze digestive disorders
- 5.2.4. Phase: Growing usage of clinical trial equipments & ancillary solutions in phase II to assess effectiveness of drug
- 5.2.5. End-Use: Expanding application of clinical trial equipment in biotechnology & pharmaceutical companies
- 5.3. Market Trend Analysis
- 5.3.1. Augmenting clinical trials and satisfactory regulatory scenario enlarge the market growth in America
- 5.3.2. Increasing number of clinical trials and the growing availability of clinical trial equipment & ancillary solutions in the Asia-Pacific region
- 5.3.3. Advancing clinical trial and drug development infrastructure with encouraging government initiatives in the EMEA region
- 5.4. Cumulative Impact of Russia-Ukraine Conflict
- 5.5. Cumulative Impact of High Inflation
- 5.6. Porter’s Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
- 5.7. Value Chain & Critical Path Analysis
- 5.8. Regulatory Framework Analysis
- 6. Clinical Trial Equipment & Ancillary Solutions Market, by Product
- 6.1. Introduction
- 6.2. Equipment
- 6.3. Services
- 6.4. Systems
- 7. Clinical Trial Equipment & Ancillary Solutions Market, by Type
- 7.1. Introduction
- 7.2. Biologic Drugs
- 7.3. Medical Devices
- 7.4. Small Molecules
- 8. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
- 8.1. Introduction
- 8.2. Phase I
- 8.3. Phase II
- 8.4. Phase III
- 8.5. Phase IV
- 9. Clinical Trial Equipment & Ancillary Solutions Market, by End-Use
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Biotechnology & Pharmaceutical Companies
- 9.4. Contract Research Organizations
- 9.5. Medical Device Companies
- 10. Clinical Trial Equipment & Ancillary Solutions Market, by Indication
- 10.1. Introduction
- 10.2. Blood Disorders
- 10.3. Cardiovascular Diseases
- 10.4. CNS & Mental Disorders
- 10.5. Digestive Disorders
- 10.6. Immunology
- 10.7. Infectious Diseases
- 10.8. Metabolic Disorders
- 10.9. Oncology
- 11. Americas Clinical Trial Equipment & Ancillary Solutions Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Finland
- 13.4. France
- 13.5. Germany
- 13.6. Israel
- 13.7. Italy
- 13.8. Netherlands
- 13.9. Norway
- 13.10. Poland
- 13.11. Qatar
- 13.12. Russia
- 13.13. Saudi Arabia
- 13.14. South Africa
- 13.15. Spain
- 13.16. Sweden
- 13.17. Switzerland
- 13.18. United Arab Emirates
- 13.19. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. RQM+ Acquires Libra Medical
- 14.3.2. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
- 14.3.3. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
- 14.3.4. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
- 14.3.5. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
- 14.3.6. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
- 14.3.7. Clario Launches Cloud-Based Image Viewer for Clinical Trials
- 14.3.8. ClinChoice continues expansion with CRO acquisition
- 14.3.9. Suvoda launches purpose-built software platform
- 14.3.10. Huma acquires Alcedis to expand clinical trial platform
- 14.3.11. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
- 14.3.12. RQM+ Launches Clinical Trial Services
- 14.3.13. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
- 14.3.14. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
- 14.3.15. Philips launches 12-lead ECG solution for decentralized clinical trials
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook